Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Invested Capital (2022 - 2025)

Historic Invested Capital for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $39.4 million.

  • PAVmed's Invested Capital changed N/A to $39.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.4 million, marking a year-over-year change of. This contributed to the annual value of $22.1 million for FY2024, which is 934.0% up from last year.
  • PAVmed's Invested Capital amounted to $39.4 million in Q3 2025.
  • In the past 5 years, PAVmed's Invested Capital ranged from a high of $70.9 million in Q2 2022 and a low of $1.7 million during Q3 2023
  • Its 4-year average for Invested Capital is $35.1 million, with a median of $25.4 million in 2024.
  • As far as peak fluctuations go, PAVmed's Invested Capital plummeted by 9729.77% in 2023, and later skyrocketed by 12092.7% in 2024.
  • Over the past 4 years, PAVmed's Invested Capital (Quarter) stood at $44.6 million in 2022, then crashed by 54.73% to $20.2 million in 2023, then grew by 9.34% to $22.1 million in 2024, then soared by 78.64% to $39.4 million in 2025.
  • Its Invested Capital was $39.4 million in Q3 2025, compared to $44.3 million in Q2 2025 and $51.6 million in Q1 2025.